Keap1‐nrf2 protein-protein interaction inhibitors: design, pharmacological properties and therapeutic potential

HIGHLIGHTS

• who: Enrique Crisman from the Instituto de Investigaciu00f3n Sanitaria La Princesa, Madrid, Spain de Farmacologu00eda y Terapu00e9utica, Facultad de have published the research: KEAP1u2010NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential, in the Journal: (JOURNAL)

SUMMARY

@@

ACRONYMS

LAY DEFINITIONS

• Design: Design is the creation of a plan or convention for the construction of an object, system or measurable human interaction. Design has different connotations in different fields
• chronic diseases: Diseases which have one or more of the following characteristics: they are permanent . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.